Sulthiame
Back to searchMolecule Structure
Scientific Name
Sulthiame
Description of the Drug
Sulthiame is a carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory epilepsies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08329
http://www.drugbank.ca/drugs/DB08329
Brand Name(s)
Conadil, Ospolot, Trolone
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase | PROTEIN FAMILY | INHIBITOR | CHEMBL2095180 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL38898 | ||
| Human Metabolome Database | HMDB0258622 | ||
| DrugBank | DB08329 | ||
| PubChem: Thomson Pharma | 14800055 | ||
| PubChem | 5356 | ||
| Nikkaji | J4.400H | ||
| PDBe | OSP | ||
| BindingDB | 26999 | ||
| EPA CompTox Dashboard | DTXSID4023626 | ||
| DrugCentral | 2540 | ||
| Brenda | 165531 | 226914 | 2253 |
| ChemicalBook | CB9889259 | ||
| rxnorm | SULTHIAME | ||
| ChEBI | 32171 | ||
| ZINC | ZINC000000002119 |
